Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: The X-tract AMI registry

Journal of Interventional Cardiology

Volumn 20, Issue 1, 2007, Pages 44-50

  Young, John J ^a   Cox, David A ^b   Stuckey, Thomas ^c   Babb, Joseph ^d   Turco, Mark ^e   Lansky, Alexandra J ^f   Mehran, Roxana ^f   Stone, Gregg W ^f  

^a Swedish Heart and Vascular Institute   (United States)

^b Mid Carolina Cardiology   (United States)

^c MOSES CONE HEALTH SYSTEM   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e WASHINGTON ADVENTIST HOSPITAL   (United States)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DEVICE; EPICARDIUM; FEASIBILITY STUDY; FEMALE; HEART MUSCLE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SAPHENOUS VEIN GRAFT; THROMBECTOMY; THROMBUS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CANADA; CORONARY THROMBOSIS; CORONARY VESSELS; FEMALE; GRAFT OCCLUSION, VASCULAR; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; SAPHENOUS VEIN; SEVERITY OF ILLNESS INDEX; STENTS; THROMBECTOMY; TREATMENT OUTCOME; UNITED STATES;

EID: 33846483829     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00223.x     Document Type: Article

References (49)

1. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-risk plaque: Part 1: Evolving concepts. J Am Coll Cardiol 2005;46:937-954.
2. Davies MJ, Thomas AC. Plaque fissuring: The cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-373.
3. Falk E. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death: Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
4. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
5. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580.
6. Kotani J, Nanto S, Mintz GS, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002;106:1672-1677.
7. Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112-1117.
8. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
9. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the "no reflow" phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
10. Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995;76:861-868.
11. Kondo M, Nakano A, Saito D, et al. Assessment of "microvascular no-reflow phenomenon" using technectium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998;32:898-903.
12. Wu KC, Zerhouni EA, Judd Rm, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.
13. Ishinger T. Thrombectomy with the X-Sizer catheter system in the coronary circulation: Initial results from a multi-center study. J Invasive Cardiol 2001;13:81-88.
14. Stone GW, Cox DA, Low R, et al. Safety and efficacy of a novel device for treatment of thrombotic and athersosclerotic lesions in native coronary arteries and saphenous vein grafts. Catheter Cardiovasc Interv 2003;58:419-427.
15. Costantini CO, Stone GW, Mehran R, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 2004;44:305-312.
16. Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998;31:23-30.
17. Rodriguez A, Bernardi V, Fernandez M, et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction. Am J Cardiol 1998;81:1286-1291.
18. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-679.
19. Al Suwaidi J, Berger PB, Holmes DR. Coronary artery stents. JAMA 2000;284:1828-1836.
20. The EPISTENT Investigators. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
21. Ellis SG, Lincoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998;32:1619-1623.
22. van't Hof AW, Liem A, Suryapranta H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-2306.
23. Gibson CM, Cannon CP, Daly WL, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
24. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation 1999;99:1945-1950.
25. deLemos JA, Braunwald E. ST-segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-1294.
26. Stone GW, Peterson MA, Lansky AJ, et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-597.
27. Hoffmann R, Haager P, Arning J, et al. Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function. Am J Cardiol 2003;92:1015-1019.
28. Angeja BG, Gunda M, Murphy SA, et al. TIMI myocardial perfusion grade and ST segment resolution: Association with infarct size as assessed by single photon emission computer tomography imaging. Circulation 2002;105:282-285.
29. Henriques JP, Zijlstra F, van't Hof AW, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003;107:2115-2119.
30. Kotani J, Mintz GS, Pregowski J, et al. Volumetric intravascular ultrasound evidence that distal embolization during acute infarct intervention contributes to inadequate myocardial perfusion grade. Am J Cardiol 2003;92:728-732.
31. Eguchi H, Ikeda H, Murohara T, et al. Endothelial injuries of coronary arteries distal to thrombotic sites: Role of adhesive interaction between endothelial P-selectin and leukocyte sialyl Lewis X. Cir Res 1999;84:525-535.
32. Dorge H, Neumann T, Behrends M, et al. Perfusion-contraction mismatch with coronary microvascular obstruction: Role of inflammation. Am J Physiol 2000;279:H2587-H2592.
33. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
34. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553.
35. Carrozza JP, Mumma M, Breall JA, et al. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 2005;46:1677-1683.
36. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. JAMA 2005;293:1063-1072.
37. Gick M, Jander N, Bestehorn HP, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005;112:1462-1469.
38. Beran G, Lang I, Schreiber W, et al. Intracoronary thrombectomy with the X-Sizer catheter system improves epicardial flow and accelerates ST-segment resolution on patients with acute coronary syndromes. Circulation 2002;105:2355-2360.
39. Stone GW, Cox DA, Babb J, et al. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. J Am Coll Cardiol 2003;42:2007-2013.
40. Napodano M, Pasquetto G, Sacca S, et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003;42:1395-1402.
41. Kondo H, Suzuki T, Fukutomi T, et al. Effects of percutaneous coronary arterial thrombectomy during acute myocardial infarction on left ventricular remodeling. Am J Cardiol 2004;93:527-531.
42. Low AF, Lim YT, Teo SG, et al. Comparison of the X-Sizer thrombectomy device with adjunct abciximab during primary angioplasty and stenting for ST-segment elevation myocardial infarction. J Interv Cardiol 2005;18:267-273.
43. Lee CH, Tan HC, Teo SG, et al. Safety and feasibility of X-Sizer-facilitated rescue percutaneous coronary intervention: A preliminary experience. J Invasive Cardiol 2005;17:1-4.
44. Lefevre T, Garcia E, Reimers B, et al. X-Sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution. Results of the X-Sizer in AMI negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol 2005;46:246-252.
45. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966.
46. Burzotta F, Trani C, Romagnoli E, et al. Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 2005;46:371-376.
47. Kaltoft A, Bottcher M, Nielsen SS, et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction. Circulation 2006;114:40-47.
48. Antoniucci D, Valenti R, Migliorini A, et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2004;93:1033-1035.
49. Ali A, Cox D, Dib N, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006;48:244-252.